Ipsen SA
PAR:IPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ipsen SA
PAR:IPN
|
FR |
|
TMX Group Ltd
TSX:X
|
CA |
|
Kardex Holding AG
SIX:KARN
|
CH |
|
GK TNS Energo PAO
MOEX:TNSE
|
RU |
|
Native Mineral Resources Holdings Ltd
ASX:NMR
|
AU |
|
MRM SA
PAR:MRM
|
FR |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
FR |
|
M
|
Mud & Hound PCL
SET:MUD
|
TH |
|
A
|
Abl Group ASA
OSE:ABL
|
NO |
|
C
|
China Apex Group Ltd
HKEX:2011
|
HK |
|
Ashland Global Holdings Inc
NYSE:ASH
|
US |
|
Almonty Industries Inc
TSX:AII
|
CA |
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
K92 Mining Inc
TSX:KNT
|
CA |
Bankruptcy Probability
Ipsen SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ipsen SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Ipsen SA
PAR:IPN
|
13B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ipsen SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ipsen SA has total debt of 838.2m EUR. This includes both short-term (4m EUR) and long-term (834.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
